ArticleJID innovations : skin science from molecules to population health2022

Safety and Efficacy of Ritlecitinib and Brepocitinib in Alopecia Areata: Results from the Crossover Open-Label Extension of the ALLEGRO Phase 2a Trial.

Brett King et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.